Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Becoming a commercial-stage pharmaceutical company
View:
Post by ScienceFirst on May 25, 2023 8:41am

Becoming a commercial-stage pharmaceutical company

That's the exact wording and clear distinction the industry makes when a biotech, that has no revenues because still focused on R&D, moves to higher notch and is about to generate revenues.

From a R&D biotech to becoming a commercial-stage pharmaceutical company

The next few months will look very interesting both in terms of fundamentals and valuation.
Comment by Alamir1111 on May 25, 2023 9:28am
Hi sf see your heart is human  Brain is some alien inbreeding. Do me a favour put your dogs on a leash.
Comment by Alamir1111 on May 25, 2023 9:55am
Roger sr  Love the smell of napam in the morning.
Comment by Rumpl3StiltSkin on May 25, 2023 12:43pm
I'm expecting BTD and AA are getting closer, with todays important NR.
Comment by Alamir1111 on May 25, 2023 1:45pm
Just to update you guys there are other discussion boards than sh.ex Ceo .ca You can read exchange opinions . Yes broaden your horizon express your selfs. S..t was ready to vote for dylan mulvan
Comment by Donein25 on May 25, 2023 2:21pm
That's a good idea Alamir. Why don't you slide on over to CEO.CA and impart some wisdom there. 
Comment by Alamir1111 on May 25, 2023 2:30pm
A introvert??
Comment by O12009 on May 25, 2023 6:45pm
I second that motion. I hope when we all go to Vegas I get the chance to meet Alamir and all of his alias. He has 3 here that he is posting constantly. What a piece of trash.
Comment by Alamir1111 on May 25, 2023 6:52pm
Looks like you get a thressome get some lube boy
Comment by RoseHeaven on May 25, 2023 6:59pm
I already put him in ignore, I should have done it earlier. 
Comment by Alamir1111 on May 25, 2023 7:32pm
Love it instead o f facing reality or facts you choose ignore button . Hi hats of to you. But remember somebody gave his life to protect your freedom entiltennent  privilege   So  tread lighly
Comment by Alamir1111 on May 25, 2023 8:05pm
Hi Tlt got a chance to be a  destruktv  tech challenging old  school.
Comment by ScienceFirst on May 25, 2023 2:25pm
We officially first heard about "Commercialization phase" in the Feb. 7 2022 corporate presentation.  They had probably been hinted by the FDA that, if things continued to be in line with that, despite the issue of the first 12 patients, that FDA Breakthrough designation was really a high probability given that in August 2021, Ph. 1B p#5-6 had been cancer free with a single dose for ...more  
Comment by Alamir1111 on May 25, 2023 2:40pm
Smart man sf I average. 36
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250